<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Pharmacokinetics Market Reports]]></title>
    <link>http://www.reportlinker.com/report/search/isAdwords//isCountryAdwords//theme/pharmacokinetics</link>
    <description><![CDATA[Reportlinker.com Lastest Pharmacokinetics Market Reports]]></description>
    <pubDate>Wed, 22 May 2013 18:08:04 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Drug Discovery and Development : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d012377235/Drug-Discovery-and-Development-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012377235/Drug-Discovery-and-Development-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Data  integrity 4 <strong>pharmacokinetics</strong> (pk)   Defined as the quantitative analysis of the  time course of a drug   <Strong>pharmacokinetics</strong> describes what the body  does to a drug   Commonly referred to as  Adme ...]]></description>
      <pubDate>Thu, 31 Mar 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The French Clinical Trial Market : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d012664097/The-French-Clinical-Trial-Market-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012664097/The-French-Clinical-Trial-Market-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Dependent <strong>pharmacokinetics</strong>  justify a route of administration  compute and interpret a clearance  compute and interpret an elimination half life  compute and interpret a distribution volume  distinguish linear and non ...]]></description>
      <pubDate>Mon, 31 Oct 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Business]]></title>
      <link>http://www.reportlinker.com/d014229939/Drug-Discovery-and-Development-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014229939/Drug-Discovery-and-Development-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Phase ia   <Strong>pharmacokinetics</strong> and toxicity in normal  volunteers   Entails sequential blood draws and collection of  select biologic fluids   Phase ib   <Strong>pharmacokinetics</strong>, pharmacodynamics and  toxicity ...]]></description>
      <pubDate>Thu, 31 Mar 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Industry  in The United States and Europe]]></title>
      <link>http://www.reportlinker.com/d012668136/Drug-Discovery-and-Development-Industry-in-The-United-States-and-Europe.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012668136/Drug-Discovery-and-Development-Industry-in-The-United-States-and-Europe.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... In children,  including placebo effect, choice and assessment of good endpoints.    2) 10H00 - 11h00 : jean-louis steimer, steve kern, novartis pharma, basel, switzerland (1h00)  - place of <strong>pharmacokinetics</strong> ...]]></description>
      <pubDate>Mon, 31 Jan 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication Sector Brief]]></title>
      <link>http://www.reportlinker.com/d012875332/Drug-and-Medication-Sector-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012875332/Drug-and-Medication-Sector-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Demonstrated against many  diseases of domestic animals [8-14]. However, to date, studies on the  efficacy of florfenicol using <strong>pharmacokinetic</strong>/ pharmacodynamic (pk/ pd) approaches have not been carried out ...]]></description>
      <pubDate>Sat, 31 Dec 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pharmaceutical Sector  in The United States and Romania]]></title>
      <link>http://www.reportlinker.com/d012879275/Pharmaceutical-Sector-in-The-United-States-and-Romania.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012879275/Pharmaceutical-Sector-in-The-United-States-and-Romania.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Media were used for prediction of the in- vivo <strong>pharmacokinetic</strong> profiles, after oral administration as single dose. The accuracy of prediction were  analyzed by comparison of estimated versus experimental ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication Market Brief]]></title>
      <link>http://www.reportlinker.com/d012922900/Drug-and-Medication-Market-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012922900/Drug-and-Medication-Market-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... For  bioequivalence and <strong>pharmacokinetic</strong> studies.  Furthermore, these methods require a number of  procedures for sample preparation such as liquid- liquid and solid phase extraction which complicate  them. Some other ...]]></description>
      <pubDate>Wed, 29 Feb 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Transplantation Market (transplantation, blood supply) in The United States]]></title>
      <link>http://www.reportlinker.com/d012657426/Transplantation-Market-transplantation-blood-supply-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012657426/Transplantation-Market-transplantation-blood-supply-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Area under the time-concentration curve) and cmax (maximum plasma concentration) to demonstrate that the generic has similar <strong>pharmacokinetics</strong> as the brand formulation. Auc serves as 2 journal ...]]></description>
      <pubDate>Wed, 31 Aug 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Transplantation Sector Brief]]></title>
      <link>http://www.reportlinker.com/d012705801/U-S-Transplantation-Sector-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012705801/U-S-Transplantation-Sector-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Area under the time-concentration curve) and cmax (maximum plasma concentration) to demonstrate that the generic has similar <strong>pharmacokinetics</strong> as the brand formulation. Auc serves as 2 journal ...]]></description>
      <pubDate>Wed, 31 Aug 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The European Pharmaceutical Industry Brief]]></title>
      <link>http://www.reportlinker.com/d012602108/The-European-Pharmaceutical-Industry-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012602108/The-European-Pharmaceutical-Industry-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Was the pivotal study for the assessment.  The applicant provided a clinical overview outlining the <strong>pharmacokinetics</strong> and pharmacodynamics as  well as efficacy and safety of ibandronic acid based on published ...]]></description>
      <pubDate>Mon, 31 Jan 2011 23:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
